Structural considerations in the fitness landscape of a virus

Molecular Biology and Evolution

Volumn 27, Issue 8, 2010, Pages 1782-1791

  Watabe, Teruaki ^a   Kishino, Hirohisa ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

fitness landscape; fixation probability; protein structure; viral evolution

Indexed keywords

ANTIBODY; VIRUS RECEPTOR;

ADAPTATION; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CORONAVIRUS; MATHEMATICAL GENETICS; MATHEMATICAL MODEL; MICROBIAL POPULATION DYNAMICS; MOLECULAR EVOLUTION; PROTEIN PROTEIN INTERACTION; SEVERE ACUTE RESPIRATORY SYNDROME; SIMULATION; VACCINATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; CHEMICAL STRUCTURE; CHEMISTRY; EVOLUTION; GENETICS; HUMAN; MUTATION; PATHOGENICITY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REPRODUCTIVE FITNESS; SARS CORONAVIRUS; THEORETICAL MODEL;

BIOLOGICAL EVOLUTION; GENETIC FITNESS; HUMANS; MODELS, MOLECULAR; MODELS, THEORETICAL; MUTATION; PROTEIN STRUCTURE, TERTIARY; SARS VIRUS; VACCINATION; VIRUS REPLICATION;

EID: 77954966378     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msq056     Document Type: Article

References (33)

1. Beerenwinkel N, Schmidt B, Walter H, Kaiser R, Lengauer T, Hoffmann D, Korn K, Selbig J. 2002. Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci USA. 99: 8271-8276.
2. Burton DR. 2002. Antibodies, viruses and vaccines. Nat Rev Immunol. 2:706-713.
3. Cui Q, Sulea T, Schrag JD, Munger C, Hung M-N, Näm M, Cygler M, Purisima EO. 2008. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex. J Mol Biol. 379:787-802.
4. Elcock AH, Sept D, McCammon JA. 2001. Computer simulation of protein-protein interactions. J Phys Chem B. 105:1504-1518. (Pubitemid 32252337)
5. Gohlke H, Kiel C, Case DA. 2003. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol. 330:891-913.
6. Hobohm U, Sander C. 1994. Enlarged representative set of protein structures. Protein Sci. 3:522-524.
7. Holmes KV. 2003. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest. 111:1605-1609.
8. Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, Stec B, Farzan M, Marasco WA, Liddington RC. 2006. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J Biol Chem. 281: 34610-34616.
9. Insel RA, Looney RJ. 2004. The B-lymphocyte system: fundamental immunology. In: Stiehm ER, Ochs HD, Winkelstein JA, editors. Immunologic disorders in infants & children, 5th ed. Philadelphia (PA): Elsevier. p. 53-84.
10. Kimura M. 1962. On the probability of fixation of mutant genes in a population. Genetics 47:713-719.
11. Ksiazek TG, Erdman D, Goldsmith CS, et al. (26 co-authors). 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 348:1953-1965.
12. Li F, Li W, Farzan M, Harrison SC. 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864-1868.
13. Li F, Long T, Lu Y, Ouyang Q, Tang C. 2004. The yeast cell-cycle network is robustly designed. Proc Natl Acad Sci USA. 101: 4781-4786.
14. Li W, Moore MJ, Vasilieva N, et al. (12 co-authors). 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
15. Li W, Zhang C, Sui J, et al. (16 co-authors). 2005. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24:1634-1643.
16. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy. Science 282:103-107.
17. Nowak MA, Bangham CRM. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74-79.
18. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. 1996. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA. 93:4398-4402.
19. Perelson AS, Neumann AU, Matkowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
20. Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS. 2006. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem. 281:15829-15836.
21. Rota PA, Oberste MS, Monroe SS, et al. (35 co-authors). 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399.
22. Rutherford SL. 2000. From genotype to phenotype: buffering mechanisms and the storage of genetic information. Bioessays 22:1095-1105.
23. Simons KT, Bonneau R, Ruczinski I, Baker D. 1999a. Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins. 37(3 Suppl):171-176.
24. Simons KT, Ruczinski I, Kooperberg C, Fox BA, Bystroff C, Baker D. 1999b. Improved recognition of native-like protein structures using a combination of sequence-dependent and sequence-independent features of proteins. Proteins 34:82-95.
25. Song H-D, Tu C-C, Zhang G-W, et al. (59 co-authors). 2005. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA. 102: 2430-2435.
26. Sui J, Aird DR, Tamin A, et al. (16 co-authors). 2008. Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog. 4:e1000197.
27. Sui J, Li W, Murakami A, et al. (14 co-authors). 2004. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci USA. 101:2536-2541.
28. Wagner A. 2000. Robustness against mutations in genetic networks of yeast. Nat Genet. 24:355-361.
29. Watabe T, Kishino H, de Oliveira Martins L, Kitazoe Y. 2007. A likelihood-based index of protein-protein binding affinities with application to influenza HA escape from antibodies. Mol Biol Evol. 24:1627-1638.
30. Watabe T, Kishino H, Okuhara Y, Kitazoe Y. 2006. Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host. Genetics 172:1385-1396.
31. Wong SK, Li W, Moore MJ, Choe H, Farzan M. 2004. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem. 279: 3197-3201.
32. World Health Organization. 2003. Outbreak news-severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec. 78:81-83.
33. Wright S. 1931. Evolution in Mendelian populations. Genetics 16:97-159.